Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Clinical EpidemiologyReferences
- Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study.Lancet. 1997; 349: 1498-1504
- “Saving lives” our healthier nation.Stationary Office, London1999
General Register Office for Scotland. Scotland's Census; 2001. http://www.gro-scotland.gov.uk/grosweb/grosweb.nsf/pages/censushm.
Scottish Information and Statistics Division (ISD). 2002. http://www.show.scot.nhs.uk/isd/heart_disease/heart_disease.htm.
Scottish Office. Toward's a healthier Scotland—a white paper on health; 1999. http://www.scotland.gov.uk/library/documents-w7/tahs00.htm.
- Why model coronary heart disease?.Eur Heart J. 2002; 23: 110-116
- Medical management and the decline in mortality from coronary heart disease.Br Med J Clin Res Ed. 1986; 292: 33-35
- The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle.Ann Intern Med. 1984; 101: 825-836
- Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.Heart. 1999; 81: 380-386
- Explaining the decline in Coronary Heart Disease Mortality in Auckland, New Zealand between 1982 and 1993.Circulation. 2000; 102: 1151-1156
- The recent decline in mortality from coronary heart disease, 1980–1990. The effect of secular trends in risk factors and treatment.JAMA. 1997; 277: 535-542
- Limitations of the Parsonnet score for measuring risk stratified mortality in the north west of England.Heart. 2000; 84: 71-78
- Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project.Lancet. 2000; 355: 675-687
- By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?.BMJ. 1994; 308: 367-372
- The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group.N Engl J Med. 2000; 342: 1-8
- Is “saving lives” feasible? Estimating the potential for further reductions in UK coronary heart disease deaths.J Epidemiol Community Health. 2001; 54 ([abstract]): 774
Gilbert GN, Arber S, Dale A. General Household Survey, Office Of Population Censuses And Surveys; 1973. University Of Surrey; 1980. Office of Population Censuses and Surveys Social Survey Division. General Household Survey, 1994–1995 [computer file]. Colchester, Essex: UK Data Archive [distributor]; 13 May 1996. SN: 3196, SN: 3538. SN: 3804.
- Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease.N Engl J Med. 2001; 343: 1772-1777
- Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland.Eur Heart J. 2000; 21: 1833-1840
- Evidence of improving prognosis in heart failure. Trends in case fatality in 66 547 patients hospitalized between 1986 and 1995.Circulation. 2000; 102: 1126-1131
- Survival after coronary artery bypass surgery. 1–5 year survival. Data obtained from the SMR20 scheme Scotland 1983–1990.Information and Statistics Division, Edinburgh1991
- Sex difference in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991.Circulation. 1996; 93: 1981-1992
- Mortality in patients of the glasgow blood pressure clinic.J Hypertens. 1986; 4: 141-156
- Time-trends in survival and readmission following coronary artery bypass grafting in Scotland between 1981 and 1996: a retrospective observational study.BMJ. 2002; 324: 201-202
- Meta-analysis of randomized trials comparing coronary angioplasty with bypass-surgery.Lancet. 1995; 346: 1184-1189
- Long-term prognosis of different forms of coronary heart disease: the Reykjavik Study.Int J Epidemiol. 1995; 24: 58-68
- The natural history of prevalent ischaemic heart disease in middle-aged men.Eur Heart J. 2000; 21: 1052-1062
- Multiple risk factor interventions for primary prevention of coronary heart disease (Cochrane review).Cochrane Library. Issue 2. Update Software Ltd, Oxford2002
- Annual Report of the Registrar General for Scotland. General Register Office for Scotland.General Register Office for Scotland, Edinburgh1995
- Expected gains in life expectancy from various coronary heart disease risk factor modifications.Circulation. 1991; 83: 1194-1201
- How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects.BMJ. 1993; 306: 1313-1318
- Economics notes: handling uncertainty in economic evaluation.BMJ. 1999; 319: 120
- Substantial potential for reductions in UK coronary heart disease deaths.J Epidemiol Community Health. 2003; 57: 243-247
- Hypertension control.in: Puska P. Tuomilehto J. Nissinen A. Vartiainen E. The North Karelia Project. 20 Year results and experiences. National Public Health Institute, KTL, Helsinki1995
- Cost-effectiveness of the North Karelia Hypertension Program 1972–1977.Med Care. 1986; 24: 767-780
Expectation of life, by sex and selected age, Scotland, 1861 to 2000. General Register Office for Scotland, 2002. http://www.gro-scotland.gov.uk/grosweb/grosweb.nsf/pages/00sect5.
- Changes in population cholesterol levels and coronary heart disease deaths in seven countries.Eur Heart J. 1997; 18: 566-571
- Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland.BMJ. 1994; 309: 23-27
- Decline in ischaemic heart disease in Iceland and change in risk factor levels.BMJ. 1991; 302: 1371-1375
- Relationship between risk factor trends and disease trends.Ann Med. 1994; 26: 67-71
- Relations of changes in coronary disease rates and changes in risk factor levels: methodological issues and a practical example.Am J Epidemiol. 1996; 143: 1025-1034
- Regression analysis of recent changes in cardiovascular morbidity and mortality in the Netherlands.BMJ. 1997; 314: 789-791
- Blood pressure, stroke, and coronary heart disease.Lancet. 1990; 335: 765-774
- Measuring the costs and benefits of heart disease monitoring.Heart. 2000; 83: 651-656
- Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study.BMJ. 2001; 322: 1385-1388
- Survey of 3765 cardiopulmonary resuscitations in British hospitals (the BRESUS study): Methods and overall results.BMJ. 1992; 304: 1347-1351
- Collaborative overview of randomised trials of antiplatelet therapy—1: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.BMJ. 1994; 308: 81-106
- ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.BMJ. 1998; 316: 1337-1343
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients.Lancet. 1994; 343: 311-322
- Cumulative meta-analysis of therapeutic trials for myocardial infarction.N Engl J Med. 1992; 327: 248-254
- Prevention of suboptimal beta-blocker treatment in patients with myocardial infarction.Ann Pharmacother. 1999; 33: 1063-1072
- Overview of randomized trails of angiotensinconverting enzyme inhibitors on mortality and morbidity in patients with heart failure.JAMA. 1995; 273: 1450-1456
- ACE inhibitor use in patients with myocardial infarction: summary of evidence from clinical trials.Circulation. 1995; 92: 3132-3137
- General pharmacologic treatment of acute myocardial infarction.Emerg Med Clin North Am. 2001; 19: 417-431
- Randomised trials of secondary prevention programmes in coronary heart disease: Systematic review.BMJ. 2001; 323: 957-962
- Exercise-based rehabilitation for coronary heart disease (Cochrane review).Cochrane Library. Issue 2. Update Software Ltd, Oxford2002
- Blood-pressure reduction and cardiovascular risk in HOPE study.Lancet. 2001; 358: 2130-2131
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).Lancet. 1994; 344: 1383-1389
- Benefit of Heparin plus Aspirin versus aspirin alone in unstable angina.JAMA. 1996; 276: 1873
- Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.Lancet. 1994; 344: 563-570
- A British Cardiac Society Survey of the potential for the secondary prevention of coronary disease: (ASPIRE).Heart. 1996; 75: 334-342
- Coronary heart disease in Scotland. Report of a policy review.Scottish Office Public Health Policy Unit, HMSO Edinburgh1996
- Blood pressure, stroke and coronary heart disease.Lancet. 1990; 335: 827-838
- Control of blood pressure in Scotland: the rule of halves.BMJ. 1990; 300: 981-983
- Cardiovascular protection and blood pressure reduction: a meta-analysis.Lancet. 2002; 358: 1305-1315
- Compliance becomes concordance.BMJ. 1997; 314: 691-692